You must have a subscription to Real Money to view Columnist Conversations where you can get transparent market insights and witness our team of pros challenge each other's strategies and predictions in an open table daily debate.

Already a Subscriber? Please login to see the conversation.

Not a Subscriber? Try out Real Money to take advantage of the full breadth of coverage that TheStreet offers with Real Money.

Feb 11, 2016 | 11:47 AM EST
Well said, Jim C. To me it isn't so much as the Federal Reserve is missing a moment as we keep giving them the...
By

Doug Kass

|
Feb 11, 2016 | 10:59 AM EST
Possible SEC accounting investigation
Feb 11, 2016 | 10:37 AM EST
The top three biotechnology picks we have at Shark Biotechnology right now are FGEN, RARE and BMRN
By

Doug Kass

|
Feb 11, 2016 | 10:23 AM EST
Here is my cost basis in today's biotech buys: XON $29.99 SAGE $29.09 PTLA $29.29 OTIC $13.17 NVAX $4.53 NK...
By

Doug Kass

|
Feb 11, 2016 | 10:07 AM EST
And I am really happy that we are friends again after my particularly misplaced comments a few weeks ago. Live...
Feb 11, 2016 | 10:07 AM EST
Another rocky start to another day of trading. Agree with Doug Kass, biotech getting very oversold. Big Biot...
Feb 11, 2016 | 9:57 AM EST
Timing not that far off. I have it now as both a short-term short, but also setting up as a potential longer t...
Feb 11, 2016 | 9:55 AM EST
Twitter (TWTR) stock may be down, but the short $13 puts are now about 80% below where they were sold yesterda...
By

Doug Kass

|
Feb 11, 2016 | 9:49 AM EST
Coming up.. I have purchased a diversified group of conservative and very speculative biotech stocks this mron...
conversation

TBT

By

Doug Kass

|
Feb 11, 2016 | 9:28 AM EST
I bought an oddlot in premarket trading at $24.55. Bidding below $24.75 this morning.

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.